Taken together, these results suggested that inhibition of bone formation was more likely to be explained by SOST in early arthritis and by SFRP1 in late arthritis, suggesting a switch in the role of Wnt inhibitors (Fig. 6C). The gene discussed is SFRP1; the disease is arthritic joint disease.